Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-19

Clinical Trial Update: Chronic Clinical Effect of Acetazolamide [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for chronic clinical effect of Acetazolamide in hypertension and pulmonary conditions, completed Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Hypertension, Pulmonary | Phase 2, Phase 3 | Status: COMPLETED